Berbic, Marina

A/Prof Marina Berbic

Genetic Pathologist; Deputy Director - Genetics, Douglass Hanly Moir
A/Prof Marina Berbic is a Genetic Pathologist and is the the Deputy Director of Genetics at Douglass Hanly Moir.
She has undergone specialist training in Genetic Pathology at Prince of Wales Hospital and Douglass Hanly Moir Pathology. She attained Fellowship of the Royal College of Pathologists of Australasia in 2020 and joined DHM in 2021. In addition to a Bachelor of Medicine / Bachelor of Surgery, she holds a Bachelor of Medical Science, a Masters in Reproductive Health and Human Genetics and a PhD in Reproductive Medicine.
Marina is an Clinical Associate Professor at Macquarie University, a member of the Mackenzie’s Mission (Reproductive Genetic Carrier Screening) Committee, and a member of the Splice ACORD (Australasian Consortium for RNA Diagnostics) Committee. She has a particular interest in reproductive genomics and is passionate about integrating sequencing technologies in clinical decision-making and personalised patient care.

More from this expert

Podcasts iconPodcasts

This episode explores the evolving landscape of fetal Rhesus screening in pregnancy care, featuring expert insights from A/Prof Marina Berbic and Jessica Clarke. Learn how advances in cell-free DNA testing are reshaping anti-D immunoglobulin use, why updated national guidelines matter, and what healthcare professionals need to know about ordering, timing, and interpreting results.

In today's podcast, Dr Marina Berbic and Wendy Bruce explore on how reproductive carrier screening (RCS) can be effectively integrated into preconception care, highlighting key considerations in testing, interpretation, and patient support.

Podcasts iconPodcasts

A practical panel discussion on interpreting reproductive carrier screening results, with a focus on Fragile X and how GPs can support patients with clarity and confidence.

Podcasts iconPodcasts

This episode explores the evolving landscape of fetal Rhesus screening in pregnancy care, featuring expert insights from A/Prof Marina Berbic and Jessica Clarke. Learn how advances in cell-free DNA testing are reshaping anti-D immunoglobulin use, why updated national guidelines matter, and what healthcare professionals need to know about ordering, timing, and interpreting results.

Podcasts iconPodcasts

Upcoming Healthed Webcast

New Brain Health Guidelines – What GPs Can Do

Tuesday 4th August, 7pm - 9pm AEST

Speaker

Scientia Prof Kaarin Anstey

Psychologist; Director, UNSW Ageing Futures Institute; ARC Laureate Fellow; Senior Principal Research Scientist, NeuRA

Scientia Prof Kaarin Anstey translates the WHO's updated 2026 dementia risk-reduction guidelines changes into concrete actions for opportunistic risk assessment and targeted advice in everyday general practice.